Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Marimed (MRMD) over the last 10 years, with Q3 2025 value amounting to $25.5 million.

  • Marimed's Accumulated Depreciation & Amortization rose 2884.59% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.5 million, marking a year-over-year increase of 2884.59%. This contributed to the annual value of $21.6 million for FY2024, which is 4511.26% up from last year.
  • According to the latest figures from Q3 2025, Marimed's Accumulated Depreciation & Amortization is $25.5 million, which was up 2884.59% from $23.7 million recorded in Q2 2025.
  • Over the past 5 years, Marimed's Accumulated Depreciation & Amortization peaked at $25.5 million during Q3 2025, and registered a low of $462000.0 during Q1 2021.
  • In the last 5 years, Marimed's Accumulated Depreciation & Amortization had a median value of $12.1 million in 2023 and averaged $13.3 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first crashed by 454.55% in 2021, then surged by 155303.03% in 2022.
  • Over the past 5 years, Marimed's Accumulated Depreciation & Amortization (Quarter) stood at $7.0 million in 2021, then soared by 47.02% to $10.2 million in 2022, then soared by 45.89% to $14.9 million in 2023, then skyrocketed by 45.11% to $21.6 million in 2024, then rose by 17.75% to $25.5 million in 2025.
  • Its Accumulated Depreciation & Amortization was $25.5 million in Q3 2025, compared to $23.7 million in Q2 2025 and $22.0 million in Q1 2025.